Found 2031 results for "cancer"
For decades, roughly 80% of disease-causing proteins have been considered undruggable because conventional small molecules cannot block them effectively. A…
For the millions living with ischaemic heart failure, cardiac fibrosis — the progressive stiffening of heart tissue — remains one of the most difficult…
Cancer immunotherapy's next frontier may lie not in checkpoint inhibitors, but in the molecular scaffolding that suppresses immune cells from within tumors…
Epigenetic therapies for cancer have long struggled with a fundamental limitation: the DNA-methylation machinery is partially shielded by cellular…
For the millions of families navigating rare accelerated-aging disorders in children, identifying molecular rescue pathways offers a rare window of hope. New…
Understanding how cells physically move through tissue has implications far beyond basic biology — it sits at the intersection of wound healing, embryonic…
Solid tumors routinely outgrow their blood supply, creating oxygen-starved cores where most therapies lose potency. Understanding the molecular machinery that…
Antifungal resistance is quietly becoming one of medicine's most urgent unsolved problems, with immunocompromised patients — cancer survivors, transplant…
Most people assume that if a chemical passes standard toxicity screening, its biological risks are well characterized. That assumption is now seriously…
For the roughly 250,000 people worldwide living with achondroplasia — the most common form of dwarfism — treatment options have historically been limited to…
When a rare childhood cancer responds to a drug designed for a completely different tumor type, it reframes how oncologists should think about molecular…
For patients with aggressive blood cancers once considered incurable after relapse, the question of whether cellular immunotherapy delivers lasting benefit—or…
Stomach cancer remains one of the more preventable yet underdiagnosed malignancies in the Western world, largely because its early symptoms mimic common…
Adults who survived childhood cancer already carry an elevated biological age relative to their chronological years, but a critical mechanism driving that gap…
For patients facing blood cancers, the quality of treatment decisions can hinge on whether a specialist tumor board reviews their case — a resource not…
For children diagnosed with central nervous system tumors — among the most treatment-resistant cancers in pediatric oncology — conventional options often…
For anyone who grills meat regularly, the invisible risk isn't smoke or char — it's heterocyclic amines, mutagenic compounds linked to colorectal and…
For adults watching their immune resilience erode with age, the assumption has long been that telomere shortening itself is the irreversible culprit — shorten…
Most adults receiving EPO therapy for chronic kidney disease or cancer-related anemia face systemic side effects precisely because the kidneys — their sole…
Chronic low-grade inflammation is one of the most reliable biological signatures of aging, yet its molecular ignition points remain poorly mapped. A newly…